Tag: Small Pharma - Psychedelic Alpha

Our Oregon Local Jurisdiction Tracker is available now.

Read more about the article Canadian Patent Grant Strengthens Small Pharma’s International Position

Canadian Patent Grant Strengthens Small Pharma’s International Position

Post published:August 4, 2022
Post category:Press Release

Read more about the article U.S. Patent Grant to Strengthen Small Pharma’s DMT Patent Strategy With Injectable Formulation

U.S. Patent Grant to Strengthen Small Pharma’s DMT Patent Strategy With Injectable Formulation

Post published:July 27, 2022
Post category:Press Release

Read more about the article George Tziras to Succeed Peter Rands as Small Pharma Chief Executive Officer

George Tziras to Succeed Peter Rands as Small Pharma Chief Executive Officer

Post published:July 18, 2022
Post category:Press Release

Read more about the article Small Pharma Reports Fiscal First Quarter 2023 Highlights

Small Pharma Reports Fiscal First Quarter 2023 Highlights

Post published:July 17, 2022
Post category:Press Release

Read more about the article Small Pharma to Participate in the H.C. Wainwright 1st Annual Mental Health Conference on June 27, 2022

Small Pharma to Participate in the H.C. Wainwright 1st Annual Mental Health Conference on June 27, 2022

Post published:June 22, 2022
Post category:Press Release

Read more about the article Small Pharma Reports Highlights for the Fiscal Year Ended February 28, 2022

Small Pharma Reports Highlights for the Fiscal Year Ended February 28, 2022

Post published:June 9, 2022
Post category:Press Release

Read more about the article Small Pharma Expands Potential of Commercial Portfolio With DMT-Based Psychedelic Assets

Small Pharma Expands Potential of Commercial Portfolio With DMT-Based Psychedelic Assets

Post published:March 10, 2022
Post category:Press Release

Read more about the article World’s First Clinical Trial for DMT-Assisted Therapy in Major Depressive Disorder Shows Consistent Quality of Psychedelic Response in Phase I

World’s First Clinical Trial for DMT-Assisted Therapy in Major Depressive Disorder Shows Consistent Quality of Psychedelic Response in Phase I

Post published:February 22, 2022
Post category:Press Release

Read more about the article Small Pharma Reports Fiscal Third Quarter 2021 Highlights

Small Pharma Reports Fiscal Third Quarter 2021 Highlights

Post published:January 31, 2022
Post category:Press Release

Read more about the article Small Pharma Strengthens Board With Appointment of Paul Maier as Independent Director

Small Pharma Strengthens Board With Appointment of Paul Maier as Independent Director

Post published:November 18, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.